Pascal and Francis Bibliographic Databases

Help

Search results

Your search

kw.\*:("Gemcitabina")

Document Type [dt]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Language

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 25 of 1882

  • Page / 76
Export

Selection :

  • and

CBNPC 1ère ligne : place de la gemcitabineBARATA, Daprès F.Revue de pneumologie clinique (Paris). 2005, Vol 61, Num 4, pp 4S20-4S22, issn 0761-8417, CAH2Article

Enhanced antitumor effect of the combination of tumstatin gene therapy and gemcitabine in murine modelsBIN YAO; HE, Qiu-Ming; CHENG, Xian-Cheng et al.Human gene therapy. 2005, Vol 16, Num 9, pp 1075-1086, issn 1043-0342, 12 p.Article

Gestational choriocarcinoma: an unusual presentation with response to gemcitabine and surgeryPANDIAN, Zabeena; SECKL, Michael J; SMITH, Richard et al.BJOG (Oxford. Print). 2004, Vol 111, Num 4, pp 382-384, issn 1470-0328, 3 p.Article

Gemcitabine and cisplatin in refractory malignant lymphomaAVILES, Agustin; NERI, Natividad; HUERTA-GUZMAN, Judith et al.Oncology. 2004, Vol 66, Num 3, pp 197-200, issn 0030-2414, 4 p.Article

State of the Art Treatment of Solid Tumors With GemcitabineETTINGER, David S; HORTOBAGYI, Gabriel N.Seminars in oncology. 2000, Vol 27, Num 1, issn 0093-7754, 50 p., SUP2Serial Issue

EGFR mutations as a predictive marker of cytotoxic chemotherapyJIN HYUN PARKA; LEE, Se-Hoon; KEAM, Bhumsuk et al.Lung cancer. 2012, Vol 77, Num 2, pp 433-437, issn 0169-5002, 5 p.Article

Intravesical gemcitabine: A phase 1 and pharmacokinetic studyWITJES, J. A; VAN DER HEIJDEN, A. G; VRIESEMA, J. L. J et al.European urology. 2004, Vol 45, Num 2, pp 182-186, issn 0302-2838, 5 p.Article

Métastases choroïdiennes révélatrices d'un adénocarcinome bronchique et involuant sous chimiothérapie = Choroid metastases revealing pulmonary adenocarcioma resolved with chemotherapyBATTIKH, M. H; BEN YAHIA, S; BEN SAYAH, M. M et al.Revue de pneumologie clinique (Paris). 2004, Vol 60, Num 6, pp 353-356, issn 0761-8417, 4 p., CAH1Article

Enhanced radiosensitization with gemcitabine in mismatch repair-deficient HCT116 cellsROBINSON, Blaine W; IM, Michael M; LJUNGMAN, Mats et al.Cancer research (Baltimore). 2003, Vol 63, Num 20, pp 6935-6941, issn 0008-5472, 7 p.Article

Gemcitabine-associated Sweet syndrome—like eruptionMARTORELL-CALATAYUD, Antonio; REQUENA, Celia; SANMARTIN, Onofre et al.Journal of the American Academy of Dermatology. 2011, Vol 65, Num 6, pp 1236-1238, issn 0190-9622, 3 p.Article

Nécroses digitales induites par la gemcitabine = Digital necrosis related to gemcitabineSTEPHAN, Dominique; MIREA, Corina; BERTHILLOT, Caroline et al.La Presse médicale (1983). 2010, Vol 39, Num 12, pp 1336-1338, issn 0755-4982, 3 p.Article

Gemcitabine : A cytidine analogue active against solid tumorsYUK FUNG HUI; REITZ, J.American journal of health-system pharmacy. 1997, Vol 54, Num 2, pp 162-170, issn 1079-2082Article

Combination chemotherapy with gemcitabine with isolated lung perfusion for the treatment of pulmonary metastasesVAN PUTTE, Bart P; HENDRIKS, Jeroen M. H; ROMIJN, Sander et al.Journal of thoracic and cardiovascular surgery. 2006, Vol 130, Num 1, pp 125-130, issn 0022-5223, 6 p.Article

A phase I clinical trial of navitoclax, a targeted high-affinity Bcl-2 family inhibitor, in combination with gemcitabine in patients with solid tumorsCLEARY, James M; ROCHA LIMA, Caio Max S; SHAPIRO, Geoffrey I et al.Investigational new drugs. 2014, Vol 32, Num 5, pp 937-945, issn 0167-6997, 9 p.Article

A randomised, double-blind, placebo-controlled trial of trametinib, an oral MEK inhibitor, in combination with gemcitabine for patients with untreated metastatic adenocarcinoma of the pancreasINFANTE, Jeffrey R; SOMER, Bradley G; LE, Ngocdiep et al.European journal of cancer (1990). 2014, Vol 50, Num 12, pp 2072-2081, issn 0959-8049, 10 p.Article

Baseline Serum Albumin Is a Predictive Biomarker for Patients With Advanced Pancreatic Cancer Treated With Bevacizumab: A Pooled Analysis of 7 Prospective Trials of Gemcitabine-Based Therapy With or Without BevacizumabPANT, Shubham; MARTIN, Ludmila K; BEKAII-SAAB, Tanios et al.Cancer. 2014, Vol 120, Num 12, pp 1780-1786, issn 0008-543X, 7 p.Article

CHFR silencing or microsatellite instability is associated with increased antitumor activity of docetaxel or gemcitabine in colorectal cancerPELOSOF, Lorraine; YERRAM, Sashidhar R; AHUJA, Nita et al.International journal of cancer (Print). 2014, Vol 134, Num 3, pp 596-605, issn 0020-7136, 10 p.Article

Combined chemoradiotherapy with gemcitabine in patients with locally advanced inoperable transitional cell carcinoma of the urinary bladder and/or in patients ineligible for surgery: a phase I trialDE SANTIS, M; BACHNER, M; CERVENY, M et al.Annals of oncology. 2014, Vol 25, Num 9, pp 1789-1794, issn 0923-7534, 6 p.Article

De Novo Treatment of Diffuse Large B-Cell Lymphoma With Rituximab, Cyclophosphamide, Vincristine, Gemcitabine, and Prednisolone in Patients With Cardiac Comorbidity: A United Kingdom National Cancer Research Institute TrialFIELDS, Paul A; TOWNSEND, William; LINCH, David C et al.Journal of clinical oncology. 2014, Vol 32, Num 4, pp 282-287, issn 0732-183X, 6 p.Article

Determination of six chemotherapeutic agents in municipal wastewater using online solid-phase extraction coupled to liquid chromatography-tandem mass spectrometry : Emerging Contaminants: A Scientific Challenge Without BordersRABII, Farida W; SEGURA, Pedro A; FAYAD, Paul B et al.Science of the total environment. 2014, Vol 487, pp 792-800, issn 0048-9697, 9 p.Article

Gemcitabine enhances the efficacy of reovirus-based oncotherapy through anti-tumour immunological mechanismsGUJAR, S. A; CLEMENTS, D; DIELSCHNEIDER, R et al.British journal of cancer. 2014, Vol 110, Num 1, pp 83-93, issn 0007-0920, 11 p.Article

Phase I trial of everolimus, gemcitabine and cisplatin in patients with solid tumorsCOSTELLO, Brian A; BORAD, Mitesh J; YINGWEI QI et al.Investigational new drugs. 2014, Vol 32, Num 4, pp 710-716, issn 0167-6997, 7 p.Article

Phase II study of gemcitabine, oxaliplatin in combination with panitumumab in KRAS wild-type unresectable or metastatic biliary tract and gallbladder cancerHEZEL, A. F; NOEL, M. S; ZHENG, H et al.British journal of cancer. 2014, Vol 111, Num 3, pp 430-436, issn 0007-0920, 7 p.Article

Prognostic nomogram for nonresectable pancreatic cancer treated with gemcitabine-based chemotherapyHAMADA, T; NAKAI, Y; KOGURE, H et al.British journal of cancer. 2014, Vol 110, Num 8, pp 1943-1949, issn 0007-0920, 7 p.Article

Randomized controlled study of gemcitabine plus S-1 combination chemotherapy versus gemcitabine for unresectable pancreatic cancerSUDO, Kentaro; ISHIHARA, Takeshi; NAKAMURA, Kazuyoshi et al.Cancer chemotherapy and pharmacology. 2014, Vol 73, Num 2, pp 389-396, issn 0344-5704, 8 p.Article

  • Page / 76